Literature DB >> 27086765

Assessment of Deoxyribonuclease Activity in Serum Samples of Patients With Systemic Lupus Erythematosus: Fluorescence-Based Method Versus ELISA.

Aleksandra Vancevska1, Aleksandra Nikolic2, Branka Bonaci-Nikolic3, Dusan Skiljevic4, Dragica Radojkovic1.   

Abstract

BACKGROUND: We report the improvement of previously described method for determining deoxyribonuclease (DNase) activity in serum samples that uses a fluorescently labeled DNA fragment as a substrate
METHODS: Activity of serum DNase was analyzed in 31 patients with systemic lupus erythematosus (SLE) and 13 healthy individuals by fluoresence-based method and ELISA test
RESULTS: We found a mean decrease in DNase activity between cases and controls of 12.46% measured by the fluoresence-based method and of 12.21% measured by ELISA method. High level of positive correlation between two methods for DNase activity was observed: P < 0.001 and Pearson correlation coefficient 0.740. Decreased DNase activity was found in 25 of 31 SLE patients (81%) by fluoresence-based method and in 24 of 31 SLE patients (77%) by ELISA test. We also observed the significant positive correlation between titer of anti-dsDNA antibodies and DNase activity measured by both methods (P < 0.05).
CONCLUSIONS: The key improvement is the use of internal control in the fluorescence-based method, which diminishes the influence of technical errors on the obtained results and increases reliability of the assay. This improved fluorescence-based method, with additional validation, may provide an alternative to more expensive and time-consuming conventional methods, such as ELISA.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  ELISA; deoxyribonuclease activity; fluorescence; systemic lupus erythematosus

Mesh:

Substances:

Year:  2016        PMID: 27086765      PMCID: PMC6807242          DOI: 10.1002/jcla.21939

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  22 in total

1.  Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility.

Authors:  Ana Bodaño; Antonio González; Eva Balada; Josep Ordi; Patricia Carreira; Juan J Gómez-Reino; Carmen Conde
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

Review 2.  Structure and function of nucleases in DNA repair: shape, grip and blade of the DNA scissors.

Authors:  Tatsuya Nishino; Kosuke Morikawa
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Serum deoxyribonuclease I activity can be a useful diagnostic marker for the early diagnosis of unstable angina pectoris or non-ST-segment elevation myocardial infarction.

Authors:  Kousuke Fujibayashi; Yasuyuki Kawai; Michihiko Kitayama; Hironubu Akao; Ryoko Ishida; Atsushi Motoyama; Minoru Wakasa; Kenichiro Arakawa; Misuzu Ueki; Kouji Kajinami; Toshihiro Yasuda
Journal:  J Cardiol       Date:  2012-02-25       Impact factor: 3.159

5.  Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method.

Authors:  D Nadano; T Yasuda; K Kishi
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

6.  Variations in serum alkaline DNase activity. A new means for therapeutic monitoring of malignant lymphomas.

Authors:  A Economidou-Karaoglou; M Lans; H S Taper; J L Michaux; M Roberfroid
Journal:  Cancer       Date:  1988-05-01       Impact factor: 6.860

7.  Antinucleosome antibodies and decreased deoxyribonuclease activity in sera of patients with systemic lupus erythematosus.

Authors:  Krisztina Sallai; Eszter Nagy; Beata Derfalvy; Györgyi Müzes; Peter Gergely
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

Review 8.  Human deoxyribonucleases.

Authors:  A G Baranovskii; V N Buneva; G A Nevinsky
Journal:  Biochemistry (Mosc)       Date:  2004-06       Impact factor: 2.487

9.  An antibody capture bioassay (ACB) for DNase in human serum samples.

Authors:  U E Gibson; A B Chen; D L Baker; D V Sinicropi
Journal:  J Immunol Methods       Date:  1992-11-05       Impact factor: 2.303

10.  Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus.

Authors:  C Q Pan; T H Dodge; D L Baker; W S Prince; D V Sinicropi; R A Lazarus
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.